Author:
Jungk Christine,Chatziaslanidou Despina,Ahmadi Rezvan,Capper David,Bermejo Justo Lorenzo,Exner Janina,von Deimling Andreas,Herold-Mende Christel,Unterberg Andreas
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Oncology
Reference53 articles.
1. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987–96.
2. Stummer W, Reulen H-J, Meinel T, Pichlmeier U, Schumacher W, Tonn J-C, et al. Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery. 2008;62:564–76. discussion 564–76.
3. Keles GE, Chang EF, Lamborn KR, Tihan T, Chang CJ, Chang SM, et al. Volume of residual disease as a predictor of outcome in adult patients with recurrent supratentorial glioblastomas multiforme who are undergoing chemotherapy. 2004. p. 1–6.
4. Park JK, Hodges T, Arko L, Shen M, Dello-Iacono D, McNabb A, et al. Scale to predict survival after surgery for recurrent glioblastoma multiforme. J Clin Oncol. 2010;28:3838–43.
5. Bloch O, Han SJ, Cha S, Sun MZ, Aghi MK, McDermott MW, et al. Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article. J Neurosurg. 2012;117:1032–8.
Cited by
46 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献